Medicare Enrolled
Dr. Pamela Hoof, M.D.
Internal Medicine · Mesquite, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hoof from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hoof?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hoof
Dr. Pamela Hoof is an internal medicine specialist in Mesquite, TX, with 12 years of NPI registration. Based on federal Medicare data, Dr. Hoof performed 31,983 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hoof received a total of $2,745 from 29 pharmaceutical and/or device companies across 97 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hoof is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 1% volume in TX
$2,745 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗31,983
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,150 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 5,900 | $43 | $136 |
| Paclitaxel chemotherapy injection | 5,278 | $0 | $8 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,600 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 1,920 | $18 | $65 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,880 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
954 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
664 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
595 | $8 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
511 | $10 | $64 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 470 | $0 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
353 | $88 | $368 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
261 | $274 | $2,762 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
137 | $13 | $60 |
| Iron level test | 137 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
137 | $8 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
134 | $98 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
112 | $22 | $157 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
111 | $12 | $108 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
106 | $11 | $96 |
| Radiation therapy, 3+ areas, 6-10 MeV Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV. |
106 | $178 | $700 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $60 | $250 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
79 | $35 | $143 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
76 | $6 | $31 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
75 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
75 | $6 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $111 | $565 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
67 | $137 | $496 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
58 | $180 | $700 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
58 | $1 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
52 | $43 | $313 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $49 | $344 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
41 | $22 | $161 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
32 | $1 | $8 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
29 | $15 | $100 |
| New patient office visit, complex (60-74 min) | 20 | $157 | $709 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 17 | $91 | $657 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
16 | $48 | $821 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
16 | $1,173 | $4,802 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
16 | $17 | $114 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
15 | $184 | $1,067 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
15 | $5 | $26 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
13 | $62 | $264 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.2% high complexity
88.9% medium
9.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,745
Total received (2018-2024)
Avg $392/year across 7 years
Top 25% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
97
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$675
2023
$424
2022
$453
2021
$376
2020
$92
2019
$694
2018
$30
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$251
ABBVIE INC.
$92
Gilead Sciences, Inc.
$56
Merck Sharp & Dohme LLC
$47
GlaxoSmithKline, LLC.
$39
Lilly USA, LLC
$32
Sumitomo Pharma America, Inc.
$29
Kite Pharma, Inc.
$29
Celgene Corporation
$29
E.R. Squibb & Sons, L.L.C.
$23
Tempus AI, Inc
$21
PFIZER INC.
$15
Sirtex Medical Inc
$13
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$324
AbbVie Inc.
$315
Genentech USA, Inc.
$279
ABBVIE INC.
$215
Celgene Corporation
$176
Incyte Corporation
$172
Astellas Pharma US Inc
$157
Merck Sharp & Dohme Corporation
$140
GENZYME CORPORATION
$125
SOBI, INC
$115
GlaxoSmithKline, LLC.
$101
Lilly USA, LLC
$81
Gilead Sciences, Inc.
$77
Merck Sharp & Dohme LLC
$59
Pharmacyclics LLC, An AbbVie Company
$59
E.R. Squibb & Sons, L.L.C.
$56
Kite Pharma, Inc.
$49
PharmaEssentia USA Corporation
$41
Sumitomo Pharma America, Inc.
$29
AstraZeneca Pharmaceuticals LP
$23
CTI BioPharma Corp.
$21
Tempus AI, Inc
$21
Myriad Genetic Laboratories, Inc.
$19
Rigel Pharmaceuticals, Inc.
$18
GE HealthCare
$17
Seagen Inc.
$15
PFIZER INC.
$15
Sirtex Medical Inc
$13
PUMA BIOTECHNOLOGY, INC.
$13
Top 3 companies account for 33.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · BESREMI · BLENREP · CREON · CYRAMZA · Doptelet · ELIQUIS · ELITEK · EPKINLY · Fabhalta · Herceptin · IMBRUVICA · JAKAFI · KEYTRUDA · KISQALI · Kadcyla · LUTATHERA · MEKINIST · NERLYNX · OJJAARA · ORGOVYX · OXBRYTA · PLUVICTO · PRECISETUMOR · PROMACTA · Perjeta · REBLOZYL · Revlimid · Rezlidhia · SCEMBLIX · SIR-Spheres Microspheres · TECENTRIQ · Tecentriq · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XT CDX · Xtandi · YERVOY · Yescarta · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
1,859
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
DALLAS REGIONAL MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hoof is a mixed practice specialist, with above-average Medicare volume (top 1% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hoof experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Hoof performed 6,150 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hoof receive payments from pharmaceutical companies?
Yes. Dr. Hoof received a total of $2,745 from 29 companies across 97 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hoof's costs compare to other internal medicine physicians in Mesquite?
Dr. Hoof's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hoof) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Mesquite
Browse internal medicine physicians in Mesquite ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology